REDS Stock Overview
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Redsense Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr6.70 |
| 52 Week High | kr12.50 |
| 52 Week Low | kr4.51 |
| Beta | 0.65 |
| 1 Month Change | 13.18% |
| 3 Month Change | 6.69% |
| 1 Year Change | -26.86% |
| 3 Year Change | -84.77% |
| 5 Year Change | -37.96% |
| Change since IPO | 41.05% |
Recent News & Updates
Recent updates
Here's Why We're Watching Redsense Medical's (NGM:REDS) Cash Burn Situation
Jun 15
Redsense Medical (NGM:REDS) Is In A Good Position To Deliver On Growth Plans
Mar 01We're Not Very Worried About Redsense Medical's (NGM:REDS) Cash Burn Rate
Nov 10Is Redsense Medical (NGM:REDS) In A Good Position To Deliver On Growth Plans?
Apr 20Shareholders Are Thrilled That The Redsense Medical (NGM:REDS) Share Price Increased 236%
Feb 24Shareholder Returns
| REDS | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | 29.8% | 2.9% | 0.9% |
| 1Y | -26.9% | -7.5% | 10.3% |
Return vs Industry: REDS underperformed the Swedish Medical Equipment industry which returned -9% over the past year.
Return vs Market: REDS underperformed the Swedish Market which returned 10.7% over the past year.
Price Volatility
| REDS volatility | |
|---|---|
| REDS Average Weekly Movement | 11.4% |
| Medical Equipment Industry Average Movement | 7.1% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in SE Market | 13.0% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: REDS's share price has been volatile over the past 3 months.
Volatility Over Time: REDS's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | Pontus Nobreus | redsensemedical.com |
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.
Redsense Medical AB (publ) Fundamentals Summary
| REDS fundamental statistics | |
|---|---|
| Market cap | kr94.07m |
| Earnings (TTM) | -kr4.51m |
| Revenue (TTM) | kr25.52m |
3.7x
P/S Ratio-20.8x
P/E RatioIs REDS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| REDS income statement (TTM) | |
|---|---|
| Revenue | kr25.52m |
| Cost of Revenue | kr12.36m |
| Gross Profit | kr13.16m |
| Other Expenses | kr17.67m |
| Earnings | -kr4.51m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 08, 2024
| Earnings per share (EPS) | -0.32 |
| Gross Margin | 51.56% |
| Net Profit Margin | -17.68% |
| Debt/Equity Ratio | 0% |
How did REDS perform over the long term?
See historical performance and comparison